课题基金 / 基金详情

项目摘要

项目成果

HARALD VON BOEHMER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Immunologies! tolerance that is mediated by FoxpS-expressingregulatory T cells has obvious therapeutic triplications for intervention in autoimmunity, transplant rejection and allergy. Recent years have seen considerable progress in understanding the role of antigen-specific receptors on Treg that are involved in ntra- and extra-thymic generation of Treg and their recruitment to specific sites of antigen deposition. The atter facilitates effective suppression of co-recruited effector cells. Antigen-specific Treg are generated when the TCR of developing thymocytes binds to cognate TCR-ligands expressed by thymic epithelial cells, but it is not clear to what extent expression of ligands by cortical epithelial cells and/or cross-presentation by hemopoietic cells contribute to Treg generation. Furthermore, it is unclear whether regulation of expression by the AIRE transcription factor can contribute. With regard to Treg generation by subimmunogenic delivery of TCR-ligands in peripheral lymphoid tissue, it is not clear whether results obtained in TCR transgenic mice can be extrapolated to wt mice and exploited to specifically suppress unwanted immune responses. Finally, there is very little information on molecular mechanisms involved in Treg-mediated suppression in vivo. In order to understand better the intrathymic process of Treg generation and its possible regulation by the AIRE transcription factor, we propose in Aim 1 to analyze the generation of FoxpS-expressingthymocytes with a transgenic T cell receptor (TCR-HA) specific for peptide 107-119 of influenza hemagglutinin (HA) in reaggregate fetal thymic organ cultures (RFTOC) in which cortical and medullary epithelial cells differ in their expression of TCR ligands that are able to induce Treg. In Aim 2 we propose to induce Treg with specificity for foreign ligands with the goal to intervene with transplant rejection, graft versus host disease and allergy by exploring the translation of results obtained in TCR transgenic mice into wt mice. Aim 3 will deal with the correlation of Foxp3 promoter binding and regulated gene expression in Treg as well as gene expression analysis in regulated versus non-regulated CD8+ effector cells with the goal to identify molecular mechanisms that govern Treg-mediated suppression of T effector function.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1084/jem.20040249
发表时间: 2004-05-17
期刊: JOURNAL OF EXPERIMENTAL MEDICINE
影响因子: 15.3
作者: [Apostolou, I, von Boehmer, H]
通讯作者: von Boehmer, H
Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope.
通过强烈的激动剂胰岛素模拟蛋白的耐受性疫苗接种,预防小鼠中1型糖尿病。
DOI: 10.1084/jem.20110574
发表时间: 2011-07-04
期刊: The Journal of experimental medicine
影响因子: --
作者: [Daniel C, Weigmann B, Bronson R, von Boehmer H]
通讯作者: von Boehmer H
DOI: 10.2217/imt.09.29
发表时间: 2009-07
期刊: Immunotherapy
影响因子: 2.8
作者: [Daniel C, Nolting J, von Boehmer H]
通讯作者: von Boehmer H
DOI: 10.1084/jem.20101156
发表时间: 2010-07-05
期刊: The Journal of experimental medicine
影响因子: --
作者: [Merkenschlager M, von Boehmer H]
通讯作者: von Boehmer H
6
    Molecular Pathways in T Cell Development and T-ALL
    • 批准号:
      7780947
    • 项目类别:
    • 资助金额:
      $21.23万
    • 财政年份:
      2010
    • 负责人:
      HARALD VON BOEHMER
    • 依托单位:
    Molecular Pathways in T Cell Development and Thymic Lymphoma
    • 批准号:
      6989689
    • 项目类别:
    • 资助金额:
      $21.01万
    • 财政年份:
      2004
    • 负责人:
      HARALD VON BOEHMER
    • 依托单位:
    pTa-controlled reporter to identify lymphoid precursor
    • 批准号:
      7003715
    • 项目类别:
    • 资助金额:
      $41.75万
    • 财政年份:
      2003
    • 负责人:
      HARALD VON BOEHMER
    • 依托单位:
    Extrathymic T cell precursors: commitment and efficacy
    • 批准号:
      7529944
    • 项目类别:
    • 资助金额:
      $39.41万
    • 财政年份:
      2003
    • 负责人:
      HARALD VON BOEHMER
    • 依托单位:
    海外基金